Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 62 for “"Zoledronic acid"”.
-
Development of calcium phosphate based drug delivery systems for local application of zoledronic acid
… antiporotic, nitrogen-containing, bisphosphonate zoledronic acid (ZOL) demonstrated a strong affinity to calcium phosphates. It has been shown to significantly impact anabolic and catabolic pathways in bone remodelling towards reduction of osteoclast activity. The effects of locally applied ZOL on …
-
Molecular and cellular studies of zoledronic acid : a potent inhibitor of multiple myeloma-induced osteolysis
… mortality. This study investigated the effect of zoledronic acid, a potent nitrogen-containing bisphosphonate (BP), on myeloma cells and osteoblasts-like cells to establish the molecular and cellular mechanism responsible for the clinical effectiveness of BPs in the treatment of patients with MM. …
-
Sequential High-Impact, Free-Fall Loading and Zoledronic Acid as a Novel Pre-Treatment for Disuse-Induced Bone Loss
… free-fall loading) and/or a bisphosphonate (zoledronic acid), to counter disuse-induced bone loss of adult male rats (6 months old) subjected to 28 days of hindlimb unloading. Furthermore, we aimed to define the effects of these treatments on mechanical strength properties and bone turnover. …
-
Defining the differential effects of Zoledronic acid under pre and post-menopausal concentrations of oestradiol on anti-cancer immunity
… breast cancer often recurs in bone. Neoadjuvant Zoledronic Acid (Zol) combined with standard of care can reduce bone metastases in pre- and post- menopausal women while prolonging life in post-menopausal women. However, pre-menopausal women experience worse iDFS and increased soft tissue tumour …
-
Evaluation of parathyroid hormone and zoledronic acid in promoting bone healing after stereotactic radiation therapy for local control of osteosarcoma in an orthotopic rat model
… fracture following radiation treatment. Zoledronic acid (ZA) and parathyroid hormone (PTH) are therapeutic candidates for decreasing this fracture risk post-irradiation. Due to differing mechanisms, we hypothesized that the combined treatment with ZA and PTH would significantly improve …
-
Adjuvant bisphosphonates in early breast cancer
… which participants received either 19 doses of zoledronic acid (ZOL) in 5 years or observation. No other clinical trial has undertaken such an intensive schedule of adjuvant bisphosphonates and therefore the safety and longer term sequelae were imperative to investigate should the drug become a …
-
Efficacy and Safety of Bisphosphonates for Fracture Prevention in Osteoporosis: Systematic Reviews and Indirect Treatment Comparisons
… for two other bisphosphonates, ibandronate and zoledronic acid and the results combined with previously obtained data for the other bisphosphonates. Indirect treatment comparisons of the drugs against each other and versus placebo were performed using Bayesian and frequentist methods. Both types …
-
Anti-tumour effects of bisphosphonates in breast cancer
… The potent third generation bisphosphonate, zoledronic acid, was found to reduce cell number and increase apoptosis, mediated by inhibition of the mevalonate pathway, in human breast cancer cells in vitro. The effects on cell apoptosis were shown to be synergistic when zoledronic acid was …
-
Μελέτη δεικτών οστικού μεταβολισμού, οστεοκλαστικής δραστηριότητας και αγγειογενετικών παραγόντων σε ασθενείς με συμπαγείς όγκους και οστικές μεταστάσεις
… the effect of treatment with the biphosphonate zoledronic acid on markers of bone remodeling and c) to detect possible correlations of marker response with skeletal morbidity and clinical outcomes. Patients and Methods: Levels of soluble RANKL (sRANKL), OPG and RANKL/OPG ratio were assessed in …
-
Κλινικοί και γενετικοί παράγοντες σχετιζόμενοι με την οστεονέκρωση των γνάθων σε ασθενείς με κακοήθεια που λαμβάνουν αντιοστεοκλαστικούς παράγοντες
… in a large number of MM patients who received zoledronic acid and who were prospectively evaluated for the development of BRONJ. b) to investigate a possible association between oral health status and the risk of developing BRONJ in a large number of MM patients who received zoledronic acid. We …
-
Οστεονέκρωση των γνάθων και δείκτες οστικού μεταβολισμού και αγγειογένεσης σε ασθενείς με συμπαγείς όγκους και μεταστατική οστική νόσο
… agents.Nine patients received i.v. zoledronic acid; 9 received bevacizumab; 5 received zoledronic acid combined with bevacizumab; one received zoledronic acid and everolimus and one received zoledronic acid, bevacizumab and temsirolimus. The mean time of bisphosphonate administration …
-
Επίδραση του ζολεδρονικού οξέος σε οστικές μεταστάσεις πρωτοπαθούς καρκίνου του πνεύμονα
… aims to investigate the potential benefit of zoledronic acid (ZOL) in lung cancer patients with regard to bone alterations. Method: 160 patients with stage IIIB-IV, small cell or non-small cell lung Ca type, with or without bone metastases participated in the study. Patients were divided into …
-
Η χονδροπροστατευτική δράση του ζολεδρονικού οξέος: πειραματική μελέτη σε κονίκλους
… study is to evaluate the protective effect of zoledronic acid (ZOL), in different dose regimens, on articular cartilage and subchondral bone structure. Thirty-eight adult male rabbits underwent an anterior cruciate ligament transection and were separated into four groups: placebo group (n=8) …
-
Utilization and effectiveness of Osteoporosis Medications among Medicare Beneficiaries
… we identified new users of intravenous (IV) zoledronic acid, oral bisphosphonates, IV ibandronate, calcitonin, raloxifene, or parathyroid hormone. Cox regression analyses using IV zoledronic acid as the referent group, indicated positive associations of IV ibandronate with hip fracture …
Page 1 of 4